27M - look 2 months on Oral 3-in-1 - 1.1mg fin+5g min+ 1mg biotin
    9/11/2025

    From the encyclopedia
    Finasteride →

    Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically

    Minoxidil →

    Vasodilator used on the scalp and, at low doses, as a tablet

    Biotin →

    B vitamin, often sold as a hair supplement

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 1.1mg 1x daily 2 months
    💊 Minoxidil (oral) 5mg 1x daily 2 months
    💊 Biotin (oral) 1mg 1x daily 2 months
    💧 Derma-stamp (topical) 1mm 2x weekly 2 months
    the tone is 😀 positive with significant hair regrowth results.

    Other terms

    A 27-year-old male experienced significant hair regrowth in two months using a daily oral 3-in-1 pill containing 1.1mg finasteride, 5mg minoxidil, and 1mg biotin from LockLab, with no side effects reported. The user also uses a derma-stamp twice a week to promote blood flow and stimulate growth.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results

      research Medical treatments for male and female pattern hair loss

      212 citations , September 2008 in “Journal of The American Academy of Dermatology”
      This review discusses the various treatment options for male and female pattern hair loss and provides no new clinical results; the authors outline the most effective strategies based on existing evidence.

      research Nonsurgical Therapy for Hair Loss

      14 citations , August 2013 in “Facial Plastic Surgery Clinics of North America”
      This review discusses current and emerging medical therapies for androgenetic alopecia but reports no new clinical findings, emphasizing the importance of stabilizing the condition as a complement to surgical hair restoration.

      research Medical Treatment of Alopecia

      October 2018 in “InTech eBooks”
      This article reviews various treatments for alopecia, highlighting that minoxidil, finasteride, PRP therapy, and hair transplants are the most commonly used options, but it reports no new clinical results.

      research A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies

      December 2025 in “IP Indian Journal of Clinical and Experimental Dermatology”
      This review reports that the treatment of androgenetic alopecia is shifting from single therapies to personalized, multimodal approaches incorporating both traditional and emerging pharmacologics, regenerative strategies, nutraceuticals, cosmeceuticals, and device-based interventions, with combination regimens showing improved outcomes.

      research Hair growth and rejuvenation: An overview

      81 citations , June 2010 in “Journal of Dermatological Treatment”
      This review discusses recent advancements in hair rejuvenation strategies and assesses the potential of herbal drugs as safer alternatives, but reports no new clinical results.